Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety
Technically, both are a type of growth hormone, but more accurately, they are what is known as GHRPs, or growth hormone releasing peptides, sometimes also referred to as human growth hormone-releasing hormones, (GHRH) or growth hormone releasing factors (GHRF)
The IGF-1 test is used: To help diagnose growth hormone deficiency To sometimes diagnose growth hormone excess To evaluate pituitary function To monitor the effectiveness of treatment During the test a blood sample will be drawn from a vein in your arm
This is a gray area that requires extreme caution and expert consultation
The FDA has explicitly warned against these, stating safety concerns and lack of clinical evidence
